MENU

RLMD Relmada Therapeutics Forecast, Technical & Fundamental Analysis

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone... Show more

RLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
RLMD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RLMD is expected to report earnings to rise 28.55% to -14 cents per share on November 05

Relmada Therapeutics RLMD Stock Earnings Reports
Q3'26
Est.
$-0.14
Q2'26
Beat
by $0.08
Q1'26
Missed
by $0.01
Q4'25
Missed
by $0.10
Q3'25
Beat
by $0.15
The last earnings report on August 06 showed earnings per share of -10 cents, beating the estimate of -18 cents. With 1.56M shares outstanding, the current market capitalization sits at 482.15M.
A.I. Advisor
published General Information

General Information

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2222 Ponce de Leon Boulevard
Phone
+1 786 629-1376
Employees
17
Web
https://www.relmada.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMVRX17.610.16
+0.92%
Columbia Select Mid Cap Value R
MAILX24.780.22
+0.90%
BlackRock International Instl
LFVCX30.430.25
+0.83%
Lord Abbett Focused Small Cap Value C
EMFIX18.070.04
+0.22%
Ashmore Emerging Markets Equity Instl
JFRNX63.60N/A
N/A
Janus Henderson Forty N

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with XENE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+11.06%
XENE - RLMD
55%
Loosely correlated
-0.26%
RNAC - RLMD
38%
Loosely correlated
-2.85%
SYRE - RLMD
36%
Loosely correlated
+2.13%
GRDX - RLMD
36%
Loosely correlated
-3.70%
BCYC - RLMD
35%
Loosely correlated
+0.78%
More
Relmada Therapeutics (RLMD) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com